Prescription Required
Cresp 40mcg Prefilled Syringe 0.4ml is a prescription medication used primarily to treat anemia associated with chronic kidney disease (CKD) in patients undergoing dialysis, as well as to manage anemia caused by chemotherapy in cancer patients.
It contains Darbepoetin alfa (40mcg), a synthetic version of erythropoietin, a hormone that stimulates the production of red blood cells. This injection helps increase the number of red blood cells in the body, alleviating symptoms like fatigue and weakness, and improving the quality of life for patients affected by these conditions.
The prefilled syringe is designed for ease of use and ensures accurate dosing, making it a convenient option for patients needing regular administration.
Alcohol consumption while using Cresp 40mcg Prefilled Syringe 0.4ml should be limited as it may interfere with your body’s ability to produce red blood cells and could increase the risk of side effects. Always consult your healthcare provider regarding alcohol use while on this medication.
While liver disease does not directly affect the way Cresp works, any liver-related issues should be discussed with your doctor before using this medication to prevent complications.
Cresp is often used in patients with chronic kidney disease (CKD), particularly those on dialysis. However, if you have severe kidney issues, talk to your doctor to ensure this medication is safe for you.
Cresp 40mcg is classified as a category C drug during pregnancy. This means it is not recommended for use unless absolutely necessary. Always consult your doctor if you are pregnant or planning to become pregnant to weigh the potential risks and benefits.
Cresp is not recommended for breastfeeding mothers as it’s unclear if Darbepoetin alfa passes into breast milk. Please discuss alternative treatments with your healthcare provider.
Cresp may cause dizziness or tiredness in some individuals. If you experience any of these symptoms, avoid driving or operating heavy machinery until you feel better.
Cresp 40mcg Prefilled Syringe contains Darbepoetin alfa, a synthetic form of erythropoietin. Erythropoietin is naturally produced by the kidneys and stimulates the bone marrow to produce red blood cells. In patients with CKD or those undergoing chemotherapy, the body often fails to produce enough erythropoietin, leading to anemia. By mimicking this hormone, Darbepoetin alfa helps the body generate more red blood cells, thereby alleviating the symptoms of anemia, such as fatigue and weakness, and improving overall health.
Anemia in CKD occurs due to decreased production of erythropoietin, a hormone responsible for red blood cell production. Cresp helps correct this deficiency by stimulating the bone marrow to produce more red blood cells. In addition, chemotherapy often leads to anemia as it affects the bone marrow’s ability to produce red blood cells. Cresp helps manage this type of anemia, improving the patient's energy levels and quality of life.
Content Updated on
Friday, 31 January, 2025Prescription Required
Simplify your healthcare journey with Indian Government's ABHA card. Get your card today!
Create ABHA